US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Procaps

1.01

0.0000

Volume:- -

Turnover:660.02K

Market Cap:113.95M

PE:1.96

High:1.01

Open:1.01

Low:1.01

Close:1.01

52wk High:3.84

52wk Low:0.5000

Shares:112.82M

Float Shares:19.15M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.5158

EPS(LYR):0.4207

ROE:373.70%

ROA:6.28%

PB:2.89

PE(LYR):2.40

Loading ...

Overview Company News Filings

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026

ProCook Group PLC (PROC) Gets a Buy from Canaccord Genuity

Ascendis Pharma Reports Third Quarter 2025 Financial Results

Buy Rating for Zentalis Pharmaceuticals Driven by Promising Clinical Progress and Strategic Focus on PROC

Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress

Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials

Immunocore reports third quarter financial results and provides a business update

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

ALPHAMAB-B (09966): JSKN003 Granted FDA Fast Track Designation for PROC Treatment

Zymeworks’ ZW191: Promising Efficacy and Safety in PROC with Potential Market Leadership

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

Canaccord Genuity Sticks to Their Buy Rating for ProCook Group PLC (PROC)

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Canaccord Genuity Reaffirms Their Buy Rating on ProCook Group PLC (PROC)

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

Sonnet to Present at the MedInvest Biotech & Pharma Conference

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PROC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PROC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PROC\",,,,,undefined,":{"symbol":"PROC","market":"US","secType":"STK","nameCN":"Procaps","latestPrice":1.01,"timestamp":1738616400000,"preClose":1.01,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":19147990,"shares":112824183,"eps":0.515793,"marketStatus":"Delisted","change":0,"latestTime":"02-03 16:00:00 EST","open":1.01,"high":1.01,"low":1.01,"amount":660024.73032,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.515793,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.01,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PROC\",,,,,undefined,":{"symbol":"PROC","floatShares":19147990,"roa":"6.28%","roe":"373.70%","lyrEps":0.420729,"shares":112824183,"dividePrice":0,"high":1.01,"amplitude":0,"preClose":1.01,"low":1.01,"week52Low":0.5,"pbRate":"2.89","psRate":"0.28","week52High":3.84,"institutionHeld":0,"latestPrice":1.01,"eps":0.515793,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.515793,"open":1.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PROC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-04","symbol":"PROC","reason":null,"defaultRemindTime":1738679400000,"announcedDate":"2025-02-03","type":"delisting","dateTimestamp":1738645200000},{"market":"US","date":"2023-12-26","symbol":"PROC","fiscalQuarterEnding":"2023/09","expectedEps":0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1703566800000,"reportTimeType":"post","actualEps":0.08},{"market":"US","date":"2023-09-05","symbol":"PROC","fiscalQuarterEnding":"2023/06","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1693886400000,"reportTimeType":"pre","actualEps":0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PROC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PROC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1694062800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PROC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PROC","date":"2025-01-31","current":1.95815,"percent":0.376079,"low":-132.08308,"twenty":-14.467484,"median":4.777205,"eighty":8.574248,"high":15.174275,"avg":-17.238194,"sd":45.468463,"marketCap":179390450},"quantilePoints":[{"date":"2021-10-01","current":-103.67686,"twenty":-108.860703,"median":-106.916762,"eighty":-104.972821,"marketCap":1083112156},{"date":"2021-10-08","current":-108.752706,"twenty":-108.752706,"median":-107.996729,"eighty":-104.540834,"marketCap":1136139522},{"date":"2021-10-15","current":-104.216844,"twenty":-108.601511,"median":-104.378839,"eighty":-103.784857,"marketCap":1088753365},{"date":"2021-10-22","current":-109.832674,"twenty":-109.61668,"median":-104.540834,"eighty":-102.985681,"marketCap":1147421941},{"date":"2021-10-29","current":-112.316598,"twenty":-109.61668,"median":-105.890793,"eighty":-103.784857,"marketCap":1173371503},{"date":"2021-11-05","current":-107.996729,"twenty":-109.61668,"median":-106.484775,"eighty":-104.216844,"marketCap":1128241830},{"date":"2021-11-12","current":-111.236631,"twenty":-109.61668,"median":-106.214783,"eighty":-104.216844,"marketCap":1162089084},{"date":"2021-11-19","current":-9.268173,"twenty":-108.752706,"median":-106.484775,"eighty":-104.216844,"marketCap":1106805235},{"date":"2021-11-26","current":-121.140525,"twenty":-109.832674,"median":-106.484775,"eighty":-104.216844,"marketCap":1061675562},{"date":"2021-12-03","current":-127.062379,"twenty":-111.236631,"median":-106.808765,"eighty":-104.216844,"marketCap":1113574686},{"date":"2021-12-10","current":-128.735946,"twenty":-121.140525,"median":-107.456745,"eighty":-104.216844,"marketCap":1128241830},{"date":"2021-12-17","current":-113.931312,"twenty":-120.239373,"median":-108.050727,"eighty":-104.540834,"marketCap":998494019},{"date":"2021-12-23","current":-123.329036,"twenty":-122.505126,"median":-108.482715,"eighty":-105.059218,"marketCap":1080855673},{"date":"2021-12-31","current":-125.517547,"twenty":-123.354783,"median":-109.832674,"eighty":-105.275212,"marketCap":1100035784},{"date":"2022-01-07","current":-119.72443,"twenty":-123.560761,"median":-110.804644,"eighty":-105.296811,"marketCap":1049264901},{"date":"2022-01-14","current":-117.79339,"twenty":-123.354783,"median":-112.316598,"eighty":-105.469605,"marketCap":1032341274},{"date":"2022-01-21","current":-117.535919,"twenty":-123.38053,"median":-113.931312,"eighty":-105.707199,"marketCap":1030084790},{"date":"2022-01-28","current":-120.110637,"twenty":-123.251794,"median":-116.184191,"eighty":-105.85429,"marketCap":1052649627},{"date":"2022-02-04","current":-122.299149,"twenty":-123.123058,"median":-117.664654,"eighty":-105.913256,"marketCap":1071829738},{"date":"2022-02-11","current":-114.9612,"twenty":-122.994322,"median":-117.664654,"eighty":-106.203983,"marketCap":1007519954},{"date":"2022-02-18","current":-102.602549,"twenty":-122.556621,"median":-117.535919,"eighty":-105.913256,"marketCap":899208738},{"date":"2022-02-25","current":-115.991087,"twenty":-122.299149,"median":-115.991087,"eighty":-105.897489,"marketCap":1016545888},{"date":"2022-03-04","current":-121.655469,"twenty":-122.299149,"median":-116.634767,"eighty":-106.101231,"marketCap":1066188529},{"date":"2022-03-11","current":-115.476143,"twenty":-122.299149,"median":-116.763503,"eighty":-106.352246,"marketCap":1012032921},{"date":"2022-03-18","current":-108.395666,"twenty":-122.299149,"median":-115.926719,"eighty":-106.352246,"marketCap":949979620},{"date":"2022-03-25","current":-114.31752,"twenty":-122.299149,"median":-115.733615,"eighty":-106.419977,"marketCap":1001878745},{"date":"2022-04-01","current":-108.524402,"twenty":-122.299149,"median":-114.9612,"eighty":-106.527974,"marketCap":951107862},{"date":"2022-04-08","current":-109.425554,"twenty":-122.299149,"median":-114.31752,"eighty":-106.63597,"marketCap":959005555},{"date":"2022-04-14","current":-102.988757,"twenty":-122.247655,"median":-112.532592,"eighty":-106.344068,"marketCap":902593464},{"date":"2022-04-22","current":-102.988757,"twenty":-122.01593,"median":-111.807813,"eighty":-105.881721,"marketCap":902593464},{"date":"2022-04-29","current":-102.988757,"twenty":-121.861447,"median":-110.912641,"eighty":-105.577602,"marketCap":902593464},{"date":"2022-05-06","current":-8.389413,"twenty":-121.655469,"median":-110.70478,"eighty":-104.870611,"marketCap":846181372},{"date":"2022-05-13","current":-8.614026,"twenty":-121.55248,"median":-109.832674,"eighty":-104.216844,"marketCap":868836468},{"date":"2022-05-20","current":-8.814477,"twenty":-121.114778,"median":-109.489922,"eighty":-103.71947,"marketCap":889054562},{"date":"2022-05-27","current":-8.959893,"twenty":-120.960295,"median":-109.425554,"eighty":-103.040251,"marketCap":903721705},{"date":"2022-06-03","current":-10.514843,"twenty":-120.754317,"median":-109.425554,"eighty":-102.812886,"marketCap":1060558602},{"date":"2022-06-10","current":-10.112039,"twenty":-120.239373,"median":-109.425554,"eighty":-101.408929,"marketCap":1019930614},{"date":"2022-06-17","current":-14.275795,"twenty":-120.110637,"median":-109.425554,"eighty":-14.897944,"marketCap":957877313},{"date":"2022-06-24","current":-14.460758,"twenty":-119.90466,"median":-108.752706,"eighty":-14.460758,"marketCap":970287973},{"date":"2022-07-01","current":-14.309425,"twenty":-119.853166,"median":-108.331299,"eighty":-14.460758,"marketCap":960133797},{"date":"2022-07-08","current":-14.763426,"twenty":-119.775924,"median":-108.158725,"eighty":-14.470847,"marketCap":990596326},{"date":"2022-07-15","current":-14.696166,"twenty":-119.72443,"median":-107.996729,"eighty":-14.47421,"marketCap":986083359},{"date":"2022-07-22","current":-14.29261,"twenty":-119.415464,"median":-107.47563,"eighty":-14.460758,"marketCap":959005555},{"date":"2022-07-29","current":-13.788165,"twenty":-119.209486,"median":-106.916762,"eighty":-14.34978,"marketCap":925158300},{"date":"2022-08-05","current":-12.863349,"twenty":-119.132244,"median":-106.64677,"eighty":-14.215262,"marketCap":863104999},{"date":"2022-08-12","current":-13.334165,"twenty":-118.926267,"median":-106.464627,"eighty":-13.989943,"marketCap":894695771},{"date":"2022-08-19","current":-12.871757,"twenty":-118.591553,"median":-106.356335,"eighty":-13.785878,"marketCap":863669120},{"date":"2022-08-26","current":-12.577497,"twenty":-118.43707,"median":-105.944791,"eighty":-13.145838,"marketCap":843924888},{"date":"2022-09-02","current":-11.241206,"twenty":-118.282587,"median":-105.6748,"eighty":-12.917157,"marketCap":824744777},{"date":"2022-09-09","current":-11.225828,"twenty":-118.128104,"median":-105.296811,"eighty":-12.678386,"marketCap":823616535},{"date":"2022-09-16","current":-10.718359,"twenty":-117.947873,"median":-104.79106,"eighty":-12.27483,"marketCap":786384555},{"date":"2022-09-23","current":-10.449247,"twenty":-117.79339,"median":-104.378839,"eighty":-11.419589,"marketCap":766640323},{"date":"2022-09-30","current":-10.764492,"twenty":-117.79339,"median":-104.216844,"eighty":-11.225828,"marketCap":789769281},{"date":"2022-10-07","current":-10.249335,"twenty":-117.741896,"median":-103.783384,"eighty":-11.179695,"marketCap":751973179},{"date":"2022-10-14","current":-10.149379,"twenty":-117.664654,"median":-103.246229,"eighty":-10.856759,"marketCap":744639607},{"date":"2022-10-21","current":-10.764492,"twenty":-117.61316,"median":-102.988757,"eighty":-10.736812,"marketCap":789769281},{"date":"2022-10-28","current":-10.472313,"twenty":-117.535919,"median":-102.812886,"eighty":-10.673394,"marketCap":768332686},{"date":"2022-11-04","current":-10.795248,"twenty":-117.226953,"median":-101.958869,"eighty":-10.656848,"marketCap":792025764},{"date":"2022-11-11","current":-10.764492,"twenty":-116.660514,"median":-100.868945,"eighty":-10.656848,"marketCap":789769281},{"date":"2022-11-18","current":12.895158,"twenty":-116.300053,"median":-57.849628,"eighty":-10.621478,"marketCap":775102137},{"date":"2022-11-25","current":12.407131,"twenty":-115.96534,"median":-14.923167,"eighty":-10.480819,"marketCap":745767849},{"date":"2022-12-02","current":12.125578,"twenty":-115.862351,"median":-14.830685,"eighty":-10.380046,"marketCap":728844222},{"date":"2022-12-09","current":11.731403,"twenty":-115.836604,"median":-14.696166,"eighty":-10.278552,"marketCap":705151143},{"date":"2022-12-16","current":11.787713,"twenty":-115.682121,"median":-14.628907,"eighty":-10.198952,"marketCap":708535869},{"date":"2022-12-23","current":10.098391,"twenty":-115.373154,"median":-14.612092,"eighty":-10.149379,"marketCap":606994104},{"date":"2022-12-30","current":9.854378,"twenty":-114.9612,"median":-14.570055,"eighty":-10.112039,"marketCap":592326960},{"date":"2023-01-06","current":8.897096,"twenty":-114.9612,"median":-14.498592,"eighty":-9.995706,"marketCap":534786627},{"date":"2023-01-13","current":9.347582,"twenty":-114.652234,"median":-14.469166,"eighty":-9.490104,"marketCap":561864431},{"date":"2023-01-20","current":8.44661,"twenty":-114.420509,"median":-14.460758,"eighty":-9.285179,"marketCap":507708823},{"date":"2023-01-27","current":8.089975,"twenty":-114.085795,"median":-14.343054,"eighty":-8.8279,"marketCap":486272228},{"date":"2023-02-03","current":7.789651,"twenty":-113.09208,"median":-14.29261,"eighty":-8.66047,"marketCap":468220359},{"date":"2023-02-10","current":7.414246,"twenty":-112.402996,"median":-14.124462,"eighty":-8.521406,"marketCap":445655522},{"date":"2023-02-17","current":6.90745,"twenty":-112.126803,"median":-14.057202,"eighty":-8.389413,"marketCap":415192993},{"date":"2023-02-24","current":7.864732,"twenty":-111.846305,"median":-13.83861,"eighty":-8.243997,"marketCap":472733326},{"date":"2023-03-03","current":7.526868,"twenty":-111.463864,"median":-13.785307,"eighty":7.425509,"marketCap":452424973},{"date":"2023-03-10","current":8.46538,"twenty":-111.107035,"median":-13.334165,"eighty":7.560655,"marketCap":508837065},{"date":"2023-03-17","current":7.71457,"twenty":-110.83275,"median":-13.115572,"eighty":7.673276,"marketCap":463707392},{"date":"2023-03-24","current":8.972177,"twenty":-110.712913,"median":-12.947423,"eighty":7.744603,"marketCap":539299594},{"date":"2023-03-31","current":8.46538,"twenty":-110.706407,"median":-12.821312,"eighty":7.819684,"marketCap":508837065},{"date":"2023-04-06","current":8.840785,"twenty":-110.58865,"median":-12.594312,"eighty":7.879748,"marketCap":531401901},{"date":"2023-04-14","current":8.634312,"twenty":-110.091866,"median":-12.27483,"eighty":8.048681,"marketCap":518991241},{"date":"2023-04-21","current":9.19742,"twenty":-109.828492,"median":-12.195568,"eighty":8.086221,"marketCap":552838496},{"date":"2023-04-28","current":8.409069,"twenty":-109.760268,"median":-11.333473,"eighty":8.281432,"marketCap":505452339},{"date":"2023-05-05","current":8.559231,"twenty":-109.528543,"median":-11.241206,"eighty":8.405315,"marketCap":514478274},{"date":"2023-05-12","current":8.507613,"twenty":-109.425554,"median":-11.225828,"eighty":8.461626,"marketCap":511375609},{"date":"2023-05-19","current":11.961379,"twenty":-109.425554,"median":-11.225828,"eighty":8.48415,"marketCap":508837065},{"date":"2023-05-26","current":11.27181,"twenty":-109.425554,"median":-11.118183,"eighty":8.518875,"marketCap":479502777},{"date":"2023-06-02","current":12.067467,"twenty":-109.425554,"median":-10.99516,"eighty":8.545154,"marketCap":513350032},{"date":"2023-06-09","current":14.933211,"twenty":-109.425554,"median":-10.85676,"eighty":8.559231,"marketCap":488539994},{"date":"2023-06-16","current":15.174275,"twenty":-109.425554,"median":-10.764492,"eighty":8.634312,"marketCap":496426405},{"date":"2023-06-23","current":14.725944,"twenty":-109.425554,"median":-10.764492,"eighty":8.664345,"marketCap":481759261},{"date":"2023-06-30","current":13.794795,"twenty":-109.425554,"median":-10.749115,"eighty":8.724409,"marketCap":451296732},{"date":"2023-07-07","current":13.518899,"twenty":-109.425554,"median":-10.718359,"eighty":8.833277,"marketCap":442270797},{"date":"2023-07-14","current":13.96723,"twenty":-109.425554,"median":-10.708286,"eighty":8.915866,"marketCap":456937941},{"date":"2023-07-21","current":14.346587,"twenty":-109.156415,"median":-10.656848,"eighty":9.099815,"marketCap":469348601},{"date":"2023-07-28","current":13.484413,"twenty":-108.752706,"median":-10.639547,"eighty":9.219944,"marketCap":441142555},{"date":"2023-08-04","current":13.617877,"twenty":-108.661384,"median":-10.609791,"eighty":9.358844,"marketCap":445508851},{"date":"2023-08-11","current":13.760308,"twenty":-108.472908,"median":-10.46078,"eighty":9.465834,"marketCap":450168490},{"date":"2023-08-18","current":13.484413,"twenty":-108.344172,"median":-10.380046,"eighty":10.015802,"marketCap":441142555},{"date":"2023-08-25","current":13.449926,"twenty":-108.245248,"median":-10.341601,"eighty":11.332277,"marketCap":440014313},{"date":"2023-09-01","current":13.449926,"twenty":-108.169524,"median":-10.272401,"eighty":11.586733,"marketCap":440014313},{"date":"2023-09-08","current":6.269046,"twenty":-108.085673,"median":-10.235084,"eighty":11.483985,"marketCap":417449477},{"date":"2023-09-15","current":6.031838,"twenty":-108.006913,"median":-10.180134,"eighty":11.376333,"marketCap":401654091},{"date":"2023-09-22","current":5.981008,"twenty":-107.996729,"median":-10.149379,"eighty":11.363505,"marketCap":398269365},{"date":"2023-09-29","current":6.060812,"twenty":-107.896286,"median":-10.136302,"eighty":11.334752,"marketCap":403583385},{"date":"2023-10-06","current":5.845461,"twenty":-107.486961,"median":-10.087867,"eighty":11.314244,"marketCap":389243431},{"date":"2023-10-13","current":4.93052,"twenty":-107.348748,"median":-9.980605,"eighty":11.067159,"marketCap":328318372},{"date":"2023-10-20","current":4.049465,"twenty":-106.916762,"median":-9.530373,"eighty":10.218521,"marketCap":269649797},{"date":"2023-10-27","current":5.049123,"twenty":-106.916762,"median":-9.519187,"eighty":10.158456,"marketCap":336216065},{"date":"2023-11-03","current":4.87969,"twenty":-106.799964,"median":-9.305964,"eighty":9.974508,"marketCap":324933647},{"date":"2023-11-10","current":4.583181,"twenty":-106.7093,"median":-9.161239,"eighty":9.869394,"marketCap":305189415},{"date":"2023-11-17","current":4.032521,"twenty":-106.63597,"median":-8.825662,"eighty":9.741757,"marketCap":268521555},{"date":"2023-11-24","current":4.811916,"twenty":-106.549573,"median":-8.747362,"eighty":9.587841,"marketCap":320420679},{"date":"2023-12-01","current":4.201955,"twenty":-106.476716,"median":-8.614026,"eighty":9.465834,"marketCap":279803973},{"date":"2023-12-08","current":5.286161,"twenty":-106.464627,"median":-8.557201,"eighty":9.460203,"marketCap":352000168},{"date":"2023-12-15","current":5.03218,"twenty":-106.429487,"median":-8.434157,"eighty":9.430171,"marketCap":335087823},{"date":"2023-12-22","current":5.659084,"twenty":-106.360423,"median":-8.389413,"eighty":9.377614,"marketCap":376832771},{"date":"2023-12-29","current":8.947611,"twenty":-106.352246,"median":-8.389413,"eighty":9.37386,"marketCap":467092117},{"date":"2024-01-05","current":9.077286,"twenty":-106.310144,"median":-8.34467,"eighty":9.362598,"marketCap":473861568},{"date":"2024-01-12","current":9.876952,"twenty":-106.154682,"median":3.744484,"eighty":9.445187,"marketCap":515606516},{"date":"2024-01-19","current":9.206962,"twenty":-105.944791,"median":4.015578,"eighty":9.460203,"marketCap":480631019},{"date":"2024-01-26","current":8.882773,"twenty":-105.865954,"median":4.07488,"eighty":9.460203,"marketCap":463707392},{"date":"2024-02-02","current":7.922526,"twenty":-105.836795,"median":4.201955,"eighty":9.385122,"marketCap":413579607},{"date":"2024-02-09","current":7.326667,"twenty":-105.512804,"median":4.273964,"eighty":9.379862,"marketCap":382473980},{"date":"2024-02-16","current":7.715693,"twenty":-105.296811,"median":4.303615,"eighty":9.366352,"marketCap":402782333},{"date":"2024-02-23","current":7.725203,"twenty":-105.296811,"median":4.337502,"eighty":9.351336,"marketCap":403278759},{"date":"2024-03-01","current":6.310875,"twenty":-105.210413,"median":4.489992,"eighty":9.304246,"marketCap":329446614},{"date":"2024-03-08","current":6.570226,"twenty":-104.870611,"median":4.676369,"eighty":9.291699,"marketCap":342985516},{"date":"2024-03-15","current":6.786352,"twenty":-104.688071,"median":4.752614,"eighty":9.291271,"marketCap":354267934},{"date":"2024-03-22","current":6.710708,"twenty":-104.565132,"median":4.811916,"eighty":9.258404,"marketCap":350319088},{"date":"2024-03-28","current":6.008299,"twenty":-104.34644,"median":4.811916,"eighty":9.250187,"marketCap":313651228},{"date":"2024-04-05","current":6.159587,"twenty":-104.216844,"median":4.845802,"eighty":9.241051,"marketCap":321548921},{"date":"2024-04-12","current":5.815515,"twenty":-104.216844,"median":4.896633,"eighty":9.218161,"marketCap":303587311},{"date":"2024-04-19","current":5.835398,"twenty":-104.175166,"median":4.938992,"eighty":9.201237,"marketCap":304625294},{"date":"2024-04-26","current":5.893968,"twenty":-103.992897,"median":5.015236,"eighty":9.190177,"marketCap":307682829},{"date":"2024-05-03","current":6.418938,"twenty":-103.762079,"median":5.057595,"eighty":9.181329,"marketCap":335087823},{"date":"2024-05-10","current":5.965074,"twenty":-103.495723,"median":5.08301,"eighty":9.178649,"marketCap":311394745},{"date":"2024-05-17","current":5.576047,"twenty":-103.297723,"median":5.193142,"eighty":9.156125,"marketCap":291086392},{"date":"2024-05-24","current":5.640885,"twenty":-103.246229,"median":5.286161,"eighty":9.12875,"marketCap":294471117},{"date":"2024-05-31","current":5.662498,"twenty":-103.14324,"median":5.420183,"eighty":9.103221,"marketCap":295599359},{"date":"2024-06-07","current":5.878623,"twenty":-102.988757,"median":5.554435,"eighty":9.072964,"marketCap":306881777},{"date":"2024-06-14","current":5.554435,"twenty":-102.988757,"median":5.586854,"eighty":9.060759,"marketCap":289958150},{"date":"2024-06-21","current":5.673304,"twenty":-102.988757,"median":5.619272,"eighty":9.037873,"marketCap":296163480},{"date":"2024-06-28","current":5.424759,"twenty":-102.918409,"median":5.619272,"eighty":9.019103,"marketCap":283188699},{"date":"2024-07-05","current":5.403147,"twenty":-102.770819,"median":5.608466,"eighty":8.987193,"marketCap":282060457},{"date":"2024-07-12","current":5.424759,"twenty":-102.525307,"median":5.554435,"eighty":8.967264,"marketCap":283188699},{"date":"2024-07-15","current":5.554435,"twenty":-102.448066,"median":5.554435,"eighty":8.962351,"marketCap":289958150},{"date":"2024-08-02","current":5.208633,"twenty":-102.370824,"median":5.554435,"eighty":8.957437,"marketCap":271906281},{"date":"2024-08-09","current":4.387355,"twenty":-101.907375,"median":5.43179,"eighty":8.928564,"marketCap":229033091},{"date":"2024-08-16","current":4.171229,"twenty":-101.525916,"median":5.424759,"eighty":8.915866,"marketCap":217750673},{"date":"2024-08-23","current":4.322517,"twenty":-101.084939,"median":5.413502,"eighty":8.908977,"marketCap":225648366},{"date":"2024-08-30","current":4.257679,"twenty":-100.804147,"median":5.403147,"eighty":8.900012,"marketCap":222263640},{"date":"2024-09-06","current":3.976716,"twenty":-100.467701,"median":5.403147,"eighty":8.891367,"marketCap":207596496},{"date":"2024-09-13","current":3.976716,"twenty":-66.285269,"median":5.269303,"eighty":8.880994,"marketCap":207596496},{"date":"2024-09-20","current":3.890265,"twenty":-15.382212,"median":5.208633,"eighty":8.863309,"marketCap":203083529},{"date":"2024-09-27","current":4.668319,"twenty":-14.928211,"median":5.142312,"eighty":8.833277,"marketCap":243700235},{"date":"2024-10-04","current":4.841219,"twenty":-14.891218,"median":5.08301,"eighty":8.814418,"marketCap":252726169},{"date":"2024-10-11","current":4.234044,"twenty":-14.860951,"median":5.040652,"eighty":8.795603,"marketCap":221029795},{"date":"2024-10-18","current":4.408968,"twenty":-14.803781,"median":4.964406,"eighty":8.780568,"marketCap":230161333},{"date":"2024-10-25","current":4.063166,"twenty":-14.736522,"median":4.922048,"eighty":8.77471,"marketCap":212109464},{"date":"2024-10-31","current":3.890265,"twenty":-14.696166,"median":4.888161,"eighty":8.769155,"marketCap":203083529},{"date":"2024-11-08","current":3.609302,"twenty":-14.68944,"median":4.841219,"eighty":8.739426,"marketCap":188416385},{"date":"2024-11-15","current":1.718201,"twenty":-14.655811,"median":4.835039,"eighty":8.705166,"marketCap":89695225},{"date":"2024-11-22","current":2.398997,"twenty":-14.625544,"median":4.811916,"eighty":8.684979,"marketCap":125234843},{"date":"2024-11-29","current":3.2635,"twenty":-14.612092,"median":4.811916,"eighty":8.671853,"marketCap":170364516},{"date":"2024-12-06","current":3.209469,"twenty":-14.612092,"median":4.777205,"eighty":8.671853,"marketCap":167543911},{"date":"2024-12-13","current":5.057345,"twenty":-14.612092,"median":4.811916,"eighty":8.662468,"marketCap":264008588},{"date":"2024-12-20","current":5.273471,"twenty":-14.595277,"median":4.811916,"eighty":8.653083,"marketCap":275291006},{"date":"2024-12-27","current":5.338309,"twenty":-14.554922,"median":4.824233,"eighty":8.638066,"marketCap":278675732},{"date":"2025-01-03","current":5.035733,"twenty":-14.524655,"median":4.841219,"eighty":8.634312,"marketCap":262880346},{"date":"2025-01-10","current":3.630914,"twenty":-14.501114,"median":4.835039,"eighty":8.634312,"marketCap":189544627},{"date":"2025-01-17","current":3.782203,"twenty":-14.482618,"median":4.811916,"eighty":8.612764,"marketCap":197442320},{"date":"2025-01-24","current":3.587689,"twenty":-14.475892,"median":4.811916,"eighty":8.579954,"marketCap":187288143},{"date":"2025-01-31","current":3.436401,"twenty":-14.467484,"median":4.777205,"eighty":8.574248,"marketCap":179390450}],"updateTime":1770408777783},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PROC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602302197","title":"Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602302197","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602302197?lang=en_us&edition=fundamental","pubTime":"2026-01-10 07:01","pubTimestamp":1767999660,"startTime":"0","endTime":"0","summary":"- Rapidly transforming into a leading global biopharma companyCOPENHAGEN, Denmark, Jan.  09, 2026  (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/09/3216381/0/en/Ascendis-Pharma-Provides-Business-and-Strategic-Roadmap-Update-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550494.USD","LU1791710582.SGD","LU1732800096.USD","BK4585","LU1074936037.SGD","LU0314104364.USD","BK4137","LU0528227936.USD","LU2111349929.HKD","BK4081","LU0795875086.SGD","LU0795875169.SGD","LU0912757837.SGD","LU1720051108.HKD","SGA","PROC","LU0029874061.USD","LU2028103732.USD","BK4215","LABU","LU1244550577.SGD","BK4534","MAA","BK4127","LU1791710400.SGD","LU0106261372.USD","LU2133065610.SGD","LU2089283258.USD","BK4125","LU0098860793.USD","LU1244550221.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1989772923.USD","BK4588","LU2347655156.SGD","LU2023251221.USD","HCSG","BK4007","LU0557290698.USD","BK4581","OS","LU1548497426.USD","XBI","LU1989772840.SGD","EMA","LU0971096721.USD","XLV","BK4504","LU0882574139.USD"],"gpt_icon":0},{"id":"2601589700","title":"Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601589700","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601589700?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:00","pubTimestamp":1767704400,"startTime":"0","endTime":"0","summary":"Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approvalInitiation of the A","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/06/3213566/0/en/Zentalis-Pharmaceuticals-Provides-Corporate-Update-and-Highlights-Key-Milestones-and-Expected-Momentum-in-the-Azenosertib-Development-Program-for-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROC","BK4007"],"gpt_icon":0},{"id":"2586619572","title":"ProCook Group PLC (PROC) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2586619572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586619572?lang=en_us&edition=fundamental","pubTime":"2025-11-27 00:56","pubTimestamp":1764176177,"startTime":"0","endTime":"0","summary":"In a report released today, from Canaccord Genuity reiterated a Buy rating on ProCook Group PLC, with a price target of p54.00. The word on The Str...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/procook-group-plc-proc-gets-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/procook-group-plc-proc-gets-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PROC"],"gpt_icon":0},{"id":"2583007873","title":"Ascendis Pharma Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583007873","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583007873?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:01","pubTimestamp":1762981260,"startTime":"0","endTime":"0","summary":"– Q3 2025 revenue of 143.1 million for YORVIPATH and 50.7 million for SKYTROFA – Q3 2025 operating profit of 11.0 million – TransCon CNP (navepegritide) under FDA Priority Review for the treatment of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/12/3186726/0/en/Ascendis-Pharma-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","OS","ET","BK4125","BK4087","BK4215","BK4588","BK4561","PROC","CHMP","BK4581","BK4097","BK4590","MAA","SGA","BK4585","BK4007"],"gpt_icon":0},{"id":"2582380901","title":"Buy Rating for Zentalis Pharmaceuticals Driven by Promising Clinical Progress and Strategic Focus on PROC","url":"https://stock-news.laohu8.com/highlight/detail?id=2582380901","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582380901?lang=en_us&edition=fundamental","pubTime":"2025-11-11 09:25","pubTimestamp":1762824318,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on ZNTL stock, giving a Buy rating on October 27. Tyler Van Buren’s rating is ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-zentalis-pharmaceuticals-driven-by-promising-clinical-progress-and-strategic-focus-on-proc-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-zentalis-pharmaceuticals-driven-by-promising-clinical-progress-and-strategic-focus-on-proc-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PROC","PRGS"],"gpt_icon":0},{"id":"2582990383","title":"Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2582990383","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582990383?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:05","pubTimestamp":1762808700,"startTime":"0","endTime":"0","summary":"DENALI Phase 2 trial evaluating azenosertib in patients with Cyclin E1-positive PROC remains on track with topline data anticipated by year end 2026, with the potential to support an accelerated appro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3185034/0/en/Zentalis-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Operational-Progress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","PROC","BK4007","LU2065732104.USD","PRGS"],"gpt_icon":0},{"id":"2582010874","title":"Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2582010874","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582010874?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:35","pubTimestamp":1762781700,"startTime":"0","endTime":"0","summary":"The Company’s operating loss declined by 44% year-over-year, reflecting its continued laser focus on relentless execution and progress in operational excellence Continued progress with lead program, E","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184603/0/en/Ernexa-Therapeutics-Reports-Strong-Quarterly-Performance-Highlighting-Operational-Execution-and-Progress-Toward-First-in-Human-Cell-Therapy-Trials.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA","BK4539","PRGS","LU2065732104.USD","RA","LENZ","BK4007","PROC","BK4097"],"gpt_icon":0},{"id":"2581909528","title":"Immunocore reports third quarter financial results and provides a business update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581909528","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581909528?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430400,"startTime":"0","endTime":"0","summary":"Immunocore reports third quarter financial results and provides a business update KIMMTRAK (tebentafusp-tebn) net revenues of $103.7 million in 3Q 2025, growing by 29% year-over-year Phase 3 TEBE-AM t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3182351/0/en/Immunocore-reports-third-quarter-financial-results-and-provides-a-business-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","PROC","BK4195","BK4211","IE00B66KJ199.SGD","LU1093756168.USD","BK4121","ORR","BK4006","BK4599","BK4548","BK4533","LU1878469433.USD","IE00BFXG0V08.USD","BK4187","CM","LU2413666699.HKD","BK4007","CRS","BK4588","ATOM","BK4207","BK4567","IE0031619046.USD","LU1721428933.USD","MTD","LU2065731478.USD","OS","BK4585","LU2211817866.USD","PFS","ALT","LU0347712357.USD","IE00B19Z4B17.USD","IE00BYQQ9H92.USD","LU2413666426.HKD","LU0963586101.USD","BK4139","CTA","BK4147","IE00B7SZL793.SGD","BK4097"],"gpt_icon":0},{"id":"2581262037","title":"Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581262037","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581262037?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:30","pubTimestamp":1762342200,"startTime":"0","endTime":"0","summary":"Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map designed to accelerate treatments for a wide range of neurolog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/05/3181232/0/en/Recursion-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0347712357.USD","LU2211817866.USD","IE00BFXG0V08.USD","PROC","L","PLD","BK4588","BK4533","LU2413666426.HKD","BK4121","BK4539","BK4107","LU0053666078.USD","BK4224","LU1721428933.USD","RXRX","LU0210528500.USD","BK4585","BK4534","LU2487616109.SGD","BK4609","BK4139","LU2413666699.HKD","MTD","BK4007","LU1093756325.SGD","IE00BYQQ9H92.USD","BK4611","BK4548","BK4567","BK4171"],"gpt_icon":1},{"id":"2580721511","title":"Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2580721511","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580721511?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:15","pubTimestamp":1762175700,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Nov.  03, 2025  (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class WEE1 inhibitor for pati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179252/0/en/Zentalis-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PROC"],"gpt_icon":0},{"id":"1176229345","title":"ALPHAMAB-B (09966): JSKN003 Granted FDA Fast Track Designation for PROC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1176229345","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176229345?lang=en_us&edition=fundamental","pubTime":"2025-10-27 22:10","pubTimestamp":1761574228,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that JSKN003 has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of platinum-resistant recurrent epithelial...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROC","BK1161","09966","BK4007","BK1574"],"gpt_icon":0},{"id":"2578025630","title":"Zymeworks’ ZW191: Promising Efficacy and Safety in PROC with Potential Market Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2578025630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578025630?lang=en_us&edition=fundamental","pubTime":"2025-10-26 21:55","pubTimestamp":1761486913,"startTime":"0","endTime":"0","summary":"David Martin PhD, an analyst from Bloom Burton, maintained the Buy rating on Zymeworks. The associated price target was raised to $27.00. David Mar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/zymeworks-zw191-promising-efficacy-and-safety-in-proc-with-potential-market-leadership-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/zymeworks-zw191-promising-efficacy-and-safety-in-proc-with-potential-market-leadership-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PROC"],"gpt_icon":0},{"id":"2576016099","title":"Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2576016099","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576016099?lang=en_us&edition=fundamental","pubTime":"2025-10-18 18:00","pubTimestamp":1760781600,"startTime":"0","endTime":"0","summary":"Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL-01 trial showed rinatabart sesutecan (Rina-S) 100 mg/m2 demonstrated 50% confirmed objective response rate (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/18/3168951/0/en/Genmab-Announces-New-Data-Demonstrating-Investigational-Rinatabart-Sesutecan-Rina-S-Achieved-Anti-Tumor-Activity-in-Heavily-Pretreated-Patients-with-Advanced-Endometrial-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4080","BK4007","BK4231","L","ORR","LU2487616109.SGD","PROC","EC","BK4585","BK4161","CR","LU0053666078.USD","LU0210528500.USD","ADC","BK4201","BK4588"],"gpt_icon":0},{"id":"2575754876","title":"Canaccord Genuity Sticks to Their Buy Rating for ProCook Group PLC (PROC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2575754876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575754876?lang=en_us&edition=fundamental","pubTime":"2025-10-16 04:56","pubTimestamp":1760561783,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst reiterated a Buy rating on ProCook Group PLC today and set a price target of p54.00. The company’s shares closed today at...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-procook-group-plc-proc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-sticks-to-their-buy-rating-for-procook-group-plc-proc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PROC"],"gpt_icon":0},{"id":"2575428062","title":"Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2575428062","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575428062?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:05","pubTimestamp":1760385900,"startTime":"0","endTime":"0","summary":"Presentations feature data from first-in-human Phase 1 study including Cyclin E1 biomarker findings, supporting late-stage development of azenosertibSAN DIEGO, Oct.  13, 2025  (GLOBE NEWSWIRE) -- Zent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165795/0/en/Zentalis-Pharmaceuticals-Announces-Four-Azenosertib-Posters-Presentations-at-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK1184","BK4139","BK4539","LU0572940350.SGD","BK4202","LU0572939691.SGD","01336","BK1550","PROC","LENZ","BK1584","BK4007","LU0264606111.USD"],"gpt_icon":0},{"id":"2572682185","title":"Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572682185","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572682185?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:20","pubTimestamp":1759353600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct.  01, 2025  (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/01/3160016/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","MNQmain","NQmain","TQQQ","NVIW.SI","SQQQ","BK4007","USAW.SI","USJW.SI","PROC",".IXIC","TSYW.SI","QID","QLD"],"gpt_icon":1},{"id":"2569718041","title":"Canaccord Genuity Reaffirms Their Buy Rating on ProCook Group PLC (PROC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569718041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569718041?lang=en_us&edition=fundamental","pubTime":"2025-09-23 20:55","pubTimestamp":1758632139,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst reiterated a Buy rating on ProCook Group PLC today and set a price target of p54.00. The company’s shares opened today at...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-procook-group-plc-proc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-procook-group-plc-proc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PROC"],"gpt_icon":0},{"id":"2569878250","title":"Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2569878250","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569878250?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:00","pubTimestamp":1758542400,"startTime":"0","endTime":"0","summary":"- Kaplan-Meier analyses show for the first time that median Overall Survival exceeds 25 months for Platinum Resistantand Refractory Ovarian Cancer Patients receiving stenoparib/2X-121 twice daily - Tw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/22/3153846/0/en/Allarity-Therapeutics-Presents-New-Phase-2-Clinical-Data-for-Stenoparib-2X-121-Showing-Landmark-Median-Overall-Survival-Has-Now-Surpassed-25-Months.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4211","BK4007","BK4539","PROC","BK4139","LARK","ALLR"],"gpt_icon":0},{"id":"2568265907","title":"Sonnet to Present at the MedInvest Biotech & Pharma Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2568265907","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568265907?lang=en_us&edition=fundamental","pubTime":"2025-09-19 21:00","pubTimestamp":1758286800,"startTime":"0","endTime":"0","summary":"Live webcast presentation on Thursday, September 25th at 9:40 AM PTPRINCETON, N.J., Sept.  19, 2025  (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the \"Company\" or \"Sonnet\")","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/19/3153192/0/en/Sonnet-to-Present-at-the-MedInvest-Biotech-Pharma-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","BK4571","01698","BK4139","IE00B12V2V27.USD","TME","BK4535","BK4108","BK4565","BK4007","BK4509","SG9999011746.SGD","LU1023057109.AUD","SONN","LU0456842615.SGD","IE00BYTNYN87.SGD","PROC","BK4548","IE00BYQNZ168.SGD","BK4531","BK4526","LU0359202008.SGD","LU2039709279.SGD","BK4552","BK4563"],"gpt_icon":0},{"id":"2564761333","title":"Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2564761333","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564761333?lang=en_us&edition=fundamental","pubTime":"2025-09-03 05:00","pubTimestamp":1756846800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept.  02, 2025  (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/02/3143201/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ",".IXIC","IE00BKPKM429.USD","BK4007","BK4588","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","PROC","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","IE00BGHQF748.EUR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}